{"title":"A44002PZS 电子医生通知以促进严重主动脉瓣狭窄的识别和管理:随机对照 DETECT AS 试验的原理、设计和方法。","authors":"","doi":"10.1016/j.ahj.2024.06.009","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Symptomatic severe aortic stenosis causes substantial morbidity and mortality when left untreated, yet recent data suggest its undertreatment.</p></div><div><h3>Objective</h3><p>To evaluate the efficacy of electronic physician notification to facilitate the guideline-directed management of patients with severe aortic stenosis.</p></div><div><h3>Hypothesis</h3><p>We hypothesize that patients with severe aortic stenosis who are in the care of physicians who receive the notification are more likely to undergo aortic valve replacement within one year.</p></div><div><h3>Methods/Design</h3><p>The Electronic Physician Notification to Facilitate the Recognition and Management of Severe Aortic Stenosis (DETECT AS) trial is a randomized controlled trial and quality improvement initiative designed to evaluate the efficacy of electronic provider notification versus usual clinical care in the management of patients with severe aortic stenosis. Providers ordering an echocardiogram with findings potentially indicative of severe aortic stenosis are randomized to receive electronic notification with customized guideline recommendations for the management of severe aortic stenosis or usual care (no notification). Randomization continues until 940 patients are enrolled.</p></div><div><h3>Setting</h3><p>Multicentered, academic health system.</p></div><div><h3>Outcomes</h3><p>The primary endpoint is the proportion of patients with severe aortic stenosis receiving an aortic valve replacement within one year of the index echocardiogram. Secondary endpoints include mortality, heart failure hospitalization, transthoracic echocardiogram utilization, aortic stenosis billing code, and cardiology/Valve Team referral.</p></div><div><h3>Conclusion</h3><p>The DETECT AS trial will provide insight into whether electronic notification of providers on the presence of severe aortic stenosis and associated clinical guideline recommendations will facilitate recognition and guideline-directed management of severe aortic stenosis.</p></div><div><h3>Trial Registration</h3><p>ClinicalTrials.gov, NCT05230225, <span><span>https://clinicaltrials.gov/ct2/show/NCT05230225</span><svg><path></path></svg></span>.</p></div>","PeriodicalId":7868,"journal":{"name":"American heart journal","volume":"276 ","pages":"Pages 39-48"},"PeriodicalIF":3.7000,"publicationDate":"2024-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Electronic physician notification to facilitate the recognition and management of severe aortic stenosis: Rationale, design, and methods of the randomized controlled DETECT AS trial\",\"authors\":\"\",\"doi\":\"10.1016/j.ahj.2024.06.009\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Symptomatic severe aortic stenosis causes substantial morbidity and mortality when left untreated, yet recent data suggest its undertreatment.</p></div><div><h3>Objective</h3><p>To evaluate the efficacy of electronic physician notification to facilitate the guideline-directed management of patients with severe aortic stenosis.</p></div><div><h3>Hypothesis</h3><p>We hypothesize that patients with severe aortic stenosis who are in the care of physicians who receive the notification are more likely to undergo aortic valve replacement within one year.</p></div><div><h3>Methods/Design</h3><p>The Electronic Physician Notification to Facilitate the Recognition and Management of Severe Aortic Stenosis (DETECT AS) trial is a randomized controlled trial and quality improvement initiative designed to evaluate the efficacy of electronic provider notification versus usual clinical care in the management of patients with severe aortic stenosis. Providers ordering an echocardiogram with findings potentially indicative of severe aortic stenosis are randomized to receive electronic notification with customized guideline recommendations for the management of severe aortic stenosis or usual care (no notification). Randomization continues until 940 patients are enrolled.</p></div><div><h3>Setting</h3><p>Multicentered, academic health system.</p></div><div><h3>Outcomes</h3><p>The primary endpoint is the proportion of patients with severe aortic stenosis receiving an aortic valve replacement within one year of the index echocardiogram. Secondary endpoints include mortality, heart failure hospitalization, transthoracic echocardiogram utilization, aortic stenosis billing code, and cardiology/Valve Team referral.</p></div><div><h3>Conclusion</h3><p>The DETECT AS trial will provide insight into whether electronic notification of providers on the presence of severe aortic stenosis and associated clinical guideline recommendations will facilitate recognition and guideline-directed management of severe aortic stenosis.</p></div><div><h3>Trial Registration</h3><p>ClinicalTrials.gov, NCT05230225, <span><span>https://clinicaltrials.gov/ct2/show/NCT05230225</span><svg><path></path></svg></span>.</p></div>\",\"PeriodicalId\":7868,\"journal\":{\"name\":\"American heart journal\",\"volume\":\"276 \",\"pages\":\"Pages 39-48\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2024-06-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American heart journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0002870324001637\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American heart journal","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0002870324001637","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
摘要
背景:无症状的重度主动脉瓣狭窄如不及时治疗会导致严重的发病率和死亡率,但最近的数据表明其治疗不足:目的:评估电子医生通知对重度主动脉瓣狭窄患者进行指导性治疗的效果:我们假设,由收到通知的医生护理的重度主动脉瓣狭窄患者更有可能在 1 年内接受主动脉瓣置换术:促进识别和管理重度主动脉瓣狭窄的电子医生通知(DETECT AS)试验是一项随机对照试验和质量改进计划,旨在评估在管理重度主动脉瓣狭窄患者时,电子医生通知与常规临床护理的效果。如果医疗服务提供者订购的超声心动图检查结果可能提示重度主动脉瓣狭窄(定义为主动脉瓣面积≤1.0 平方厘米),则按 1:1 的比例随机分配接受电子通知(干预)或常规护理。通知组的医疗服务提供者会在电子病历收件箱中收到一份通知,其中概述了根据《2020 年 ACC/AHA 瓣膜性心脏病临床实践指南》对重度主动脉瓣狭窄患者进行管理的定制指南建议,适用于索引和所有后续超声心动图检查。对照组的医疗服务提供者不会收到任何通知。随机化一直持续到940名患者入组为止:多中心学术医疗系统:主要终点是重度 AS 患者在超声心动图检查后 1 年内接受主动脉瓣置换术的比例。次要终点包括死亡率、心力衰竭住院率、经胸超声心动图使用率/监测、主动脉瓣狭窄收费代码诊断和心脏病学/心脏瓣膜团队转诊:DETECT AS 试验将有助于深入了解电子通知医疗服务提供者是否存在严重主动脉瓣狭窄以及相关临床指南建议是否有助于识别严重主动脉瓣狭窄并在指南指导下进行管理:试验注册:ClinicalTrials.gov,NCT05230225,https://clinicaltrials.gov/ct2/show/NCT05230225。
Electronic physician notification to facilitate the recognition and management of severe aortic stenosis: Rationale, design, and methods of the randomized controlled DETECT AS trial
Background
Symptomatic severe aortic stenosis causes substantial morbidity and mortality when left untreated, yet recent data suggest its undertreatment.
Objective
To evaluate the efficacy of electronic physician notification to facilitate the guideline-directed management of patients with severe aortic stenosis.
Hypothesis
We hypothesize that patients with severe aortic stenosis who are in the care of physicians who receive the notification are more likely to undergo aortic valve replacement within one year.
Methods/Design
The Electronic Physician Notification to Facilitate the Recognition and Management of Severe Aortic Stenosis (DETECT AS) trial is a randomized controlled trial and quality improvement initiative designed to evaluate the efficacy of electronic provider notification versus usual clinical care in the management of patients with severe aortic stenosis. Providers ordering an echocardiogram with findings potentially indicative of severe aortic stenosis are randomized to receive electronic notification with customized guideline recommendations for the management of severe aortic stenosis or usual care (no notification). Randomization continues until 940 patients are enrolled.
Setting
Multicentered, academic health system.
Outcomes
The primary endpoint is the proportion of patients with severe aortic stenosis receiving an aortic valve replacement within one year of the index echocardiogram. Secondary endpoints include mortality, heart failure hospitalization, transthoracic echocardiogram utilization, aortic stenosis billing code, and cardiology/Valve Team referral.
Conclusion
The DETECT AS trial will provide insight into whether electronic notification of providers on the presence of severe aortic stenosis and associated clinical guideline recommendations will facilitate recognition and guideline-directed management of severe aortic stenosis.
期刊介绍:
The American Heart Journal will consider for publication suitable articles on topics pertaining to the broad discipline of cardiovascular disease. Our goal is to provide the reader primary investigation, scholarly review, and opinion concerning the practice of cardiovascular medicine. We especially encourage submission of 3 types of reports that are not frequently seen in cardiovascular journals: negative clinical studies, reports on study designs, and studies involving the organization of medical care. The Journal does not accept individual case reports or original articles involving bench laboratory or animal research.